Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
NCT07184021
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Urinary Bladder Cancer
Interventions
DRUG:
Gemcitabine and Cisplatin (DD GC)
Sponsor
Assiut University